Rigel Pharmaceuticals reported $63.55M in Current Liabilities for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acura Pharmaceuticals ACUR:US 1.11M 6.57M
Applied Genetic Technologies AGTC:US $ 24.11M 2.4M
Arrowhead Research ARWR:US $ 138.86M 1.82M
AstraZeneca AZN:LN 22594M 1055M
Celldex Therapeutics CLDX:US $ 14.56M 1.97M
Daiichi Sankyo 4568:JP Y 355195M 19149M
Immunogen IMGN:US $ 84.12M 16.83M
Intrexon XON:US $ 28.99M 0.12M
IONIS PHARMACEUT IONS:US $ 241M 38.78M
Sangamo Biosciences SGMO:US $ 118.53M 9.36M